IL109633A - Tnf receptor promoter - Google Patents

Tnf receptor promoter

Info

Publication number
IL109633A
IL109633A IL10963394A IL10963394A IL109633A IL 109633 A IL109633 A IL 109633A IL 10963394 A IL10963394 A IL 10963394A IL 10963394 A IL10963394 A IL 10963394A IL 109633 A IL109633 A IL 109633A
Authority
IL
Israel
Prior art keywords
tnf receptor
receptor promoter
promoter
sequence
upstream
Prior art date
Application number
IL10963394A
Other languages
English (en)
Other versions
IL109633A0 (en
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL10963394A priority Critical patent/IL109633A/xx
Publication of IL109633A0 publication Critical patent/IL109633A0/xx
Priority to DE69532115T priority patent/DE69532115T2/de
Priority to AT95919786T priority patent/ATE254173T1/de
Priority to US08/737,371 priority patent/US5959094A/en
Priority to AU25468/95A priority patent/AU699280B2/en
Priority to JP52974795A priority patent/JP3663211B2/ja
Priority to PCT/US1995/005853 priority patent/WO1995031206A1/fr
Priority to ES95919786T priority patent/ES2206505T3/es
Priority to EP95919786A priority patent/EP0759759B1/fr
Priority to PT95919786T priority patent/PT759759E/pt
Priority to DK95919786T priority patent/DK0759759T3/da
Priority to ZA953841A priority patent/ZA953841B/xx
Priority to CA002189984A priority patent/CA2189984C/fr
Priority to CY0500024A priority patent/CY2524B1/xx
Publication of IL109633A publication Critical patent/IL109633A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL10963394A 1994-05-11 1994-05-11 Tnf receptor promoter IL109633A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter
CA002189984A CA2189984C (fr) 1994-05-11 1995-05-11 Promoteurs du recepteur p75 du facteur de necrose tumorale
PCT/US1995/005853 WO1995031206A1 (fr) 1994-05-11 1995-05-11 Promoteurs du recepteur p75 du facteur de necrose tumorale
EP95919786A EP0759759B1 (fr) 1994-05-11 1995-05-11 Promoteurs du recepteur p75 du facteur de necrose tumorale
US08/737,371 US5959094A (en) 1994-05-11 1995-05-11 p75 TNF receptor promoters
AU25468/95A AU699280B2 (en) 1994-05-11 1995-05-11 p75 TNF receptor promoters
JP52974795A JP3663211B2 (ja) 1994-05-11 1995-05-11 ｐ７５ＴＮＦ受容体プロモーター
DE69532115T DE69532115T2 (de) 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren
ES95919786T ES2206505T3 (es) 1994-05-11 1995-05-11 Promotores para el receptor p75 del factor de necrosis tumoral.
AT95919786T ATE254173T1 (de) 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren
PT95919786T PT759759E (pt) 1994-05-11 1995-05-11 Promotores para o receptor do tnf p75
DK95919786T DK0759759T3 (da) 1994-05-11 1995-05-11 P75-TNF-receptorpromotorer
ZA953841A ZA953841B (en) 1994-05-11 1995-05-11 P75 TNF receptor promoters
CY0500024A CY2524B1 (en) 1994-05-11 2005-04-18 P75 tnf receptor promoters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter

Publications (2)

Publication Number Publication Date
IL109633A0 IL109633A0 (en) 1994-08-26
IL109633A true IL109633A (en) 2005-05-17

Family

ID=11066126

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter

Country Status (13)

Country Link
EP (1) EP0759759B1 (fr)
JP (1) JP3663211B2 (fr)
AT (1) ATE254173T1 (fr)
AU (1) AU699280B2 (fr)
CA (1) CA2189984C (fr)
CY (1) CY2524B1 (fr)
DE (1) DE69532115T2 (fr)
DK (1) DK0759759T3 (fr)
ES (1) ES2206505T3 (fr)
IL (1) IL109633A (fr)
PT (1) PT759759E (fr)
WO (1) WO1995031206A1 (fr)
ZA (1) ZA953841B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL178921A0 (en) * 1998-12-24 2007-03-08 Yeda Res & Dev Caspase-8 interacting proteins
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
CA2851996C (fr) 2011-11-01 2020-01-07 Resverlogix Corp. Compositions pharmaceutiques pour des quinazolinones substituees
US10125168B2 (en) 2012-09-20 2018-11-13 Toagosei Co. Ltd. Synthetic peptide for adjusting balance between presence of type 1 TNF receptor and type 2 TNF receptor and use thereof

Also Published As

Publication number Publication date
WO1995031206A1 (fr) 1995-11-23
CA2189984C (fr) 2008-03-25
EP0759759A4 (fr) 1997-11-26
DE69532115D1 (de) 2003-12-18
DE69532115T2 (de) 2004-08-26
DK0759759T3 (da) 2004-02-02
IL109633A0 (en) 1994-08-26
ZA953841B (en) 1996-01-17
ATE254173T1 (de) 2003-11-15
AU699280B2 (en) 1998-11-26
CA2189984A1 (fr) 1995-11-23
CY2524B1 (en) 2006-02-08
ES2206505T3 (es) 2004-05-16
EP0759759B1 (fr) 2003-11-12
EP0759759A1 (fr) 1997-03-05
PT759759E (pt) 2004-01-30
JPH10500304A (ja) 1998-01-13
JP3663211B2 (ja) 2005-06-22
AU2546895A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
WO1992013950A3 (fr) SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
AU4959293A (en) Microparticle preparations made from biodegradable copolymers
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
ZA964710B (en) Novel compounds, the preparation and use thereof.
EP1007537A4 (fr) Proteine receptrice designee par 2f1
WO1994005791A3 (fr) Facteur influant sur la croissance du tissu dorsal et compositions
SI0956351T1 (sl) Ligand, sosroden faktorju tumorske nekroze
WO1997012963A3 (fr) Paf-acetylhydrolase paf et son utilisation en therapie
IL109633A0 (en) TNF receptor promoter
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
MY110149A (en) Compounds for the treatment of neurodegenerative disorders
IL139604A0 (en) Novel peptides
ZA966489B (en) New protein human MP52 Arg.
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
ZA989615B (en) The use of TNF antagonists as drugs for treating septic 39disorders.
GB2325466A (en) Nucleotide sequence from goat liver
AU6676796A (en) Compounds, compositions, and methods for inhibiting replication of retroviruses and for inhibiting tumor promoter initiated transcription
ZA200202823B (en) Self-cleaving RNA sequences and their use for the control of protein synthesis.
ZA9610510B (en) Novel peptides, the preparation and use thereof.
ZA961972B (en) 3-Aryluracils and intermediates for their preparation.
McNamee Voiceprints
温儒敏 The Modernity of Wang Guowei's Literary Criticism
GB2308739A8 (en) Forming channel stops for F.E.T.'s
AU1237495A (en) Organopathy preventing, curing or ameliorating agent

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired